ICH M4 Guidelines: Complete Guide to CTD Format and Organization

ICH M4 is a suite of guidelines from the International Council for Harmonisation (ICH) that defines the Common Technical Document (CTD) format, organization, and granularity requirements for pharmaceutical regulatory submissions worldwide. These guidelines establish the standardized structure that regulatory agencies in the US, EU, Japan, and over 60 other countries require for drug application dossiers.

If you're preparing regulatory submissions, understanding ICH M4 guidelines is non-negotiable. A poorly organized dossier that doesn't follow CTD format specifications can delay your review timeline, trigger information requests, and frustrate regulatory assessors who expect standardized content placement.

In this guide, you'll learn:

• The complete ICH M4 guideline suite and how each component works together
• ICH M4Q requirements for Module 3 quality documentation
• ICH M4S specifications for Module 4 nonclinical safety data
• ICH M4E guidelines for Module 5 clinical efficacy presentation
• CTD granularity document requirements for proper document organization
• How to apply ICH M4 guidelines to your submission strategy

What Is ICH M4? Understanding the CTD Format Guidelines

ICH M4 is the designation for the International Council for Harmonisation's multidisciplinary guidelines that define the Common Technical Document (CTD) format. The "M" stands for "Multidisciplinary," indicating that these guidelines span across quality, safety, and efficacy disciplines rather than focusing on a single technical area.

The ICH M4 guidelines were developed to create a single, globally accepted format for regulatory submissions. Before CTD harmonization, sponsors had to prepare fundamentally different dossier formats for the FDA, EMA, and PMDA, multiplying preparation costs and creating inconsistencies in how data was presented to different agencies.

Key characteristics of ICH M4:

• Defines the five-module CTD organizational structure
• Specifies document granularity and naming conventions
• Establishes content requirements for quality, safety, and efficacy sections
• Enables single-dossier preparation for multi-regional submissions
• Provides foundation for electronic (eCTD) implementation

The ICH M4 guideline suite consists of four interconnected documents that work together to create the complete CTD framework. Understanding each component is essential for preparing compliant submissions.

ICH M4 Guideline Suite Overview: The Four Core Documents

The ICH M4 framework comprises four separate guidelines that collectively define the CTD format. Each guideline addresses a specific aspect of submission organization.

ICH M4 Guideline Components

Additionally, the ICH M4 Granularity Document specifies the exact document-level organization, file naming conventions, and folder structures required for electronic submissions.

How the M4 Guidelines Work Together

Think of the M4 guidelines as a hierarchical system:

1. M4 (Organization) - The parent guideline establishing the overall five-module structure
2. M4Q, M4S, M4E - Technical specifications for Modules 3, 4, and 5 respectively
3. Granularity Document - Implementation details for electronic submission format

The M4 organization guideline also specifies the content and format of Module 2, which contains the critical summary documents that regulatory reviewers use to navigate the detailed data in Modules 3-5.

CTD Format Guidelines: The Five-Module Structure

The CTD format guidelines establish a five-module organizational structure that all ICH-region regulatory submissions must follow. This structure separates region-specific administrative information from harmonized technical content.

CTD Module Structure Overview

Module 1: Regional Administrative Information

Module 1 is the only non-harmonized section of the CTD. Each regulatory authority specifies its own Module 1 requirements:

FDA Module 1 Requirements:

• FDA forms (1571, 356h, 3674)
• Cover letters and administrative correspondence
• US Prescribing Information (USPI)
• Patent and exclusivity information
• Pediatric assessments
• REMS documentation

EMA Module 1 Requirements:

• Application forms and cover letters
• Summary of Product Characteristics (SmPC)
• Package leaflet and labeling mock-ups
• Expert statements and declarations
• Orphan designation documentation
• Environmental risk assessment

Module 2: CTD Summaries and Overviews

Module 2 provides high-level summaries that allow reviewers to understand the submission without immediately diving into detailed data. The ICH M4 organization guideline specifies seven Module 2 sections:

The Quality Overall Summary (Section 2.3) must accurately reflect all Module 3 content. Inconsistencies between Module 2.3 and Module 3 are a frequent cause of regulatory information requests.

ICH M4Q: Quality Documentation Requirements

ICH M4Q (The Common Technical Document for the Registration of Pharmaceuticals for Human Use: Quality - M4Q) specifies the organization and content of Module 3, which contains all Chemistry, Manufacturing, and Controls (CMC) information.

M4Q Scope and Purpose

The ICH M4Q guideline defines:

• Document organization for drug substance (S) and drug product (P) sections
• Required content for each CMC subsection
• Placement of supporting information and regional documents
• Appendices and literature reference organization

Module 3 Structure per ICH M4Q

ICH M4Q Key Requirements

Drug Substance Documentation:

• Complete synthetic route or manufacturing process description
• In-process controls and their justifications
• Impurity profile with identification and qualification
• Specification development rationale
• Stability data supporting retest period

Drug Product Documentation:

• Formulation development history
• Manufacturing process validation
• Critical quality attributes identification
• Container closure compatibility studies
• Stability data supporting shelf life

ICH M4S: Nonclinical Safety Documentation

ICH M4S (The Common Technical Document for the Registration of Pharmaceuticals for Human Use: Safety - M4S) defines the organization of Module 4, containing all nonclinical (preclinical) pharmacology and toxicology study reports.

M4S Scope and Purpose

The ICH M4S guideline specifies:

• Organization of pharmacology studies (primary, secondary, safety)
• Pharmacokinetic study presentation (ADME)
• Toxicology study organization (acute, repeat-dose, genetic, reproductive, carcinogenicity)
• Literature references and other supporting data

Module 4 Structure per ICH M4S

ICH M4S Detailed Section Requirements

Section 4.2.1 - Pharmacology:

• 4.2.1.1: Primary Pharmacodynamic Studies
• 4.2.1.2: Secondary Pharmacodynamic Studies
• 4.2.1.3: Safety Pharmacology Studies (including ICH S7A core battery)
• 4.2.1.4: Pharmacodynamic Drug Interactions

Section 4.2.2 - Pharmacokinetics:

• 4.2.2.1: Analytical Methods and Validation Reports
• 4.2.2.2: Absorption Studies
• 4.2.2.3: Distribution Studies
• 4.2.2.4: Metabolism Studies
• 4.2.2.5: Excretion Studies
• 4.2.2.6: PK Drug Interactions (nonclinical)
• 4.2.2.7: Other PK Studies

Section 4.2.3 - Toxicology:

• 4.2.3.1: Single-Dose Toxicity
• 4.2.3.2: Repeat-Dose Toxicity
• 4.2.3.3: Genotoxicity (in vitro and in vivo)
• 4.2.3.4: Carcinogenicity (long-term studies, short-term studies)
• 4.2.3.5: Reproductive and Developmental Toxicity
• 4.2.3.6: Local Tolerance
• 4.2.3.7: Other Toxicity Studies

M4S Study Report Format

Individual nonclinical study reports in Module 4 should follow a consistent format including:

• Title page with study identification
• Study report table of contents
• Study summary
• Introduction and objectives
• Materials and methods
• Results
• Discussion and conclusions
• References
• Appendices with individual animal data

ICH M4E: Clinical Efficacy Documentation

ICH M4E (The Common Technical Document for the Registration of Pharmaceuticals for Human Use: Efficacy - M4E) specifies the organization of Module 5, containing all clinical study reports and supporting clinical data.

M4E Scope and Purpose

The ICH M4E guideline addresses:

• Clinical study report organization by study type
• Tabular listing of all clinical studies
• Case report forms and individual patient data placement
• Literature reference organization

Module 5 Structure per ICH M4E

ICH M4E Section 5.3.5 Organization

The efficacy and safety studies section (5.3.5) is typically the largest component of Module 5 and has specific subsections:

• 5.3.5.1: Study Reports of Controlled Clinical Studies Pertinent to the Claimed Indication
• 5.3.5.2: Study Reports of Uncontrolled Clinical Studies
• 5.3.5.3: Reports of Analyses of Data from More Than One Study (integrated analyses)
• 5.3.5.4: Other Clinical Study Reports

Clinical Study Report Format (ICH E3)

Clinical study reports in Module 5 must follow ICH E3 format, which specifies:

• Synopsis
• Table of contents
• List of abbreviations
• Ethics
• Investigators and study administrative structure
• Introduction
• Study objectives
• Investigational plan
• Study patients
• Efficacy evaluation
• Safety evaluation
• Discussion and overall conclusions
• Appendices (protocol, case report forms, patient data listings)

CTD Granularity Document: File and Folder Organization

The ICH M4 Granularity Document specifies the exact document-level organization, file naming conventions, and folder structures required for electronic CTD (eCTD) submissions.

Purpose of the Granularity Document

The granularity document addresses:

• Document naming conventions for each CTD section
• Folder hierarchy within each module
• File size and format recommendations
• Leaf element definitions for eCTD XML
• Regional variations in granularity requirements

CTD Granularity Principles

Granularity Requirements by Module

Module 3 Granularity:

• Drug substance information may be one document or split by section
• Manufacturing process description as single document
• Analytical methods as separate documents by test
• Stability data organized by study protocol

Module 4 Granularity:

• Each nonclinical study report as individual document
• Study reports organized by study type subfolder
• Literature references as separate documents

Module 5 Granularity:

• Each clinical study report as individual document
• Large CSRs may be split by section
• Individual patient listings as separate documents
• Integrated summaries as distinct documents

eCTD Folder Naming Conventions

The granularity document specifies exact folder naming:

ICH M4 Guidelines Comparison Table

Understanding the differences between M4Q, M4S, and M4E helps teams assign the right expertise to each module.

M4Q vs M4S vs M4E Comparison

Information Flow Between Modules

The CTD modules are interconnected, with data from one module supporting conclusions in another:

Implementing ICH M4 Guidelines in Practice

Applying ICH M4 guidelines effectively requires understanding both the letter and intent of the requirements.

Common ICH M4 Implementation Challenges

Challenge 1: Cross-Reference Consistency

• Module 2 summaries must accurately reflect Modules 3-5 data
• Inconsistencies trigger information requests
• Solution: Establish cross-reference verification processes

Challenge 2: Document Granularity Decisions

• When to combine vs. split documents
• Regional variations in granularity expectations
• Solution: Follow the granularity document precisely; when unclear, err toward more granular

Challenge 3: Multi-Regional Submissions

• Harmonized modules don't always align perfectly
• Regional Module 1 requirements vary significantly
• Solution: Build the harmonized core first, then customize Module 1

Challenge 4: Lifecycle Management

• Amendments must maintain CTD organization
• New data must be properly placed
• Solution: Use eCTD lifecycle capabilities; document placement strategy early

ICH M4 Compliance Checklist

Before submission, verify:

• [ ] Module 2 summaries consistent with Modules 3-5 data
• [ ] All M4Q sections complete for drug substance and drug product
• [ ] All M4S sections include required study types
• [ ] M4E clinical studies properly categorized
• [ ] Document naming follows granularity conventions
• [ ] Cross-references resolve correctly
• [ ] Regional Module 1 requirements addressed
• [ ] eCTD validation passes without errors

ICH M4 and eCTD: The Electronic Implementation

The ICH M4 guidelines provide the organizational framework that eCTD implements electronically. Understanding this relationship is essential for modern submissions.

CTD to eCTD Relationship

eCTD Versions and M4 Alignment

• eCTD v3.2.2: Current production standard, aligned with M4 granularity
• eCTD v4.0: Newer standard with enhanced metadata, full M4 alignment

Regional eCTD Implementation

Key Takeaways

Next Steps

Mastering ICH M4 guidelines is essential for efficient regulatory submissions, but organizing thousands of documents according to CTD specifications requires robust validation and quality control processes. Whether you're building your first IND or managing multiple NDAs, ensuring every document is properly placed and cross-referenced is critical for regulatory success.

Organizations managing regulatory submissions benefit from automated validation tools that catch errors before gateway rejection. Assyro's AI-powered platform validates eCTD submissions against FDA, EMA, and Health Canada requirements, providing detailed error reports and remediation guidance before submission.

Sources